文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脉搏波传导速度与需血管内容量扩张患者的短期结局:一项先导研究

Pulse wave velocity and short-term outcome in patients requiring intravascular volume expansion: a pilot study.
PubMed 文献 · Emerg Med J · 2019-12-24
一句话结论在ICU需血管内容量扩张的患者中,初始颈股脉搏波传导速度(cfPWV)升高与30天硬终点独立相关,cfPWV<9 m/s对排除液体扩张相关硬事件有93%阴性预测值。

该先导研究在意大利都灵S. Giovanni Bosco医院ICU前瞻性连续纳入50例需血管内容量扩张的患者,在基线和24小时后行经胸超声心动图、肺超声和cfPWV检查,记录24小时软终点和30天硬终点(死亡、急性心肌梗死、卒中、心房颤动、需透析)。达到预设复合终点(硬或软)者初始cfPWV显著高于未达到者(10.6±3.6 vs 7.4±2.2 m/s,P<0.0001)。校正混杂因素后,初始cfPWV与硬事件发生独立相关(OR=2.8,95%CI 1.36至5.97,P=0.005;ROC曲线下面积84%),cfPWV<9 m/s对液体扩张相关硬事件的阴性预测值为93%。作者认为cfPWV可能反映患者对临床指征下血管内容量扩张的耐受能力,cfPWV升高可能有助于识别液体超负荷风险更高的患者。

要点

  • 在ICU需血管内容量扩张的50例患者中,达到预设复合终点(硬或软)者初始cfPWV显著高于未达到者(10.6±3.6 vs 7.4±2.2 m/s,P<0.0001)。
  • 校正混杂因素后,初始cfPWV与30天硬事件(死亡、急性心肌梗死、卒中、心房颤动、需透析)独立相关(OR=2.8,95%CI 1.36至5.97,P=0.005;ROC曲线下面积84%)。
  • cfPWV<9 m/s对液体扩张相关硬事件的阴性预测值为93%,可用于排除液体扩张相关硬事件。
  • 作者认为cfPWV可能反映患者对临床指征下血管内容量扩张的耐受能力,cfPWV升高可能有助于识别液体超负荷风险更高的患者。

适用人群与场景

  • 在ICU中需要血管内容量扩张的连续50例患者,为前瞻性招募。

诊断标准与关键阈值

  • cfPWV<9 m/s对液体扩张相关硬事件的阴性预测值为93%。

研究设计与关键结果

  • 研究类型为先导研究,前瞻性连续纳入50例需血管内容量扩张的ICU患者,在意大利都灵S. Giovanni Bosco医院于2015年至2016年开展。
  • 所有受试者在基线和24小时后接受经胸超声心动图、肺超声评估和cfPWV研究;24小时记录软终点,30天记录硬终点(死亡、急性心肌梗死、卒中、心房颤动、需透析)。
  • 达到预设复合终点(硬或软)者初始cfPWV显著高于未达到者(10.6±3.6 vs 7.4±2.2 m/s,P<0.0001)。
  • 校正混杂因素后,初始cfPWV与硬事件发生独立相关(OR=2.8,95%CI 1.36至5.97,P=0.005;ROC曲线下面积84%)。
  • cfPWV<9 m/s对液体扩张相关硬事件的阴性预测值为93%。

证据类型、等级与局限

  • 证据类型为先导研究(前瞻性队列)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为cfPWV可能反映患者对临床指征下血管内容量扩张的耐受能力。
  • 作者认为cfPWV升高可能有助于识别液体超负荷体征和症状风险更高的患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Fluid therapy has a pivotal role in the management of acutely ill patients. However, whether or not a patient can tolerate additional intravascular volume is controversial and optimal strategy is unknown. Carotid femoral pulse wave velocity (cfPWV) evaluates arterial stiffness.

OBJECTIVE: To determine whether cfPWV can predict the ability of patients to tolerate clinically indicated acute fluid expansion.

METHODS: 50 consecutive patients requiring intravascular volume expansion were prospectively recruited in intensive care units. All subjects underwent transthoracic echocardiography, pulmonary ultrasound assessment, and a cfPWV study (S. Giovanni Bosco Hospital in Turin, Italy, between 2015 and 2016) at baseline and after 24 hours. Acute outcomes were registered at 24 hours ("soft" end points) and 30 days ('hard' end points: death, acute myocardial infarction, stroke, occurrence of atrial fibrillation, need for dialysis) after initial fluid therapy. Multivariate logistic regression was used to assess association of the initial cfPWV with outcomes.

RESULTS: cfPWV was significantly higher (10.6±3.6 vs 7.4±2.2 m/s, P<0.0001) in subjects who met the prespecified combined endpoints (hard or soft) than in those who did not. After adjustment for confounding factors, initial cfPWV was significantly and independently associated with the occurrence of hard events (OR=2.8 (95% CI 1.36 to 5.97), P=0.005; area under the receiver operating characteristic curve 84%). cfPWV of <9 m/s had a negative predictive value of 93%, excluding hard events associated with fluid expansion.

CONCLUSION: cfPWV appears to reflect the ability of the patient to tolerate an intravascular fluid expansion when clinically indicated. Increased cfPWV could help to identify subjects at greater risk of developing signs and symptoms of fluid overload.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Milan A, Maldari P, Iannaccone A, et al. Pulse wave velocity and short-term outcome in patients requiring intravascular volume expansion: a pilot study. Emerg Med J. 2019. PMID: 31874921. doi:10.1136/emermed-2018-208089

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。